selected publications
- PD-1/PD-L1 for prostate cancer: from clinical trials to practice. Expert review of clinical pharmacology. 2026 Review GET IT
- Immune thrombocytopenia in patients treated with immune checkpoint inhibitors. Blood. 2025 Academic Article GET IT
- Androgen receptor pathway signaling inhibitors in development for prostate cancer therapy. Expert opinion on investigational drugs. 2025 Review GET IT